Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tacrolimus | 2 | 2020 | 104 | 0.700 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2017 | 376 | 0.580 |
Why?
|
| Immunosuppressive Agents | 2 | 2020 | 672 | 0.540 |
Why?
|
| Drug Monitoring | 1 | 2018 | 174 | 0.510 |
Why?
|
| Mitochondria | 3 | 2015 | 747 | 0.470 |
Why?
|
| Brain Injuries, Traumatic | 3 | 2022 | 302 | 0.420 |
Why?
|
| Fetal Development | 2 | 2024 | 131 | 0.370 |
Why?
|
| Cognitive Dysfunction | 2 | 2025 | 316 | 0.270 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2025 | 649 | 0.260 |
Why?
|
| Fetal Weight | 2 | 2024 | 72 | 0.260 |
Why?
|
| Dopaminergic Neurons | 2 | 2017 | 54 | 0.240 |
Why?
|
| Biometry | 2 | 2024 | 105 | 0.230 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 1 | 2024 | 9 | 0.220 |
Why?
|
| Parkinson Disease | 3 | 2017 | 734 | 0.210 |
Why?
|
| Protein Kinases | 2 | 2017 | 331 | 0.210 |
Why?
|
| Amyloid beta-Peptides | 1 | 2025 | 226 | 0.210 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2022 | 254 | 0.200 |
Why?
|
| Repressor Proteins | 2 | 2017 | 812 | 0.180 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2024 | 1009 | 0.170 |
Why?
|
| Brain | 3 | 2025 | 3175 | 0.170 |
Why?
|
| Area Under Curve | 2 | 2020 | 321 | 0.170 |
Why?
|
| Cesarean Section | 1 | 2024 | 418 | 0.170 |
Why?
|
| Drug Administration Schedule | 2 | 2020 | 749 | 0.160 |
Why?
|
| Tablets | 1 | 2018 | 35 | 0.140 |
Why?
|
| Drug Compounding | 1 | 2018 | 42 | 0.140 |
Why?
|
| Graft Rejection | 2 | 2020 | 559 | 0.140 |
Why?
|
| Brain Injuries | 1 | 2022 | 716 | 0.130 |
Why?
|
| Kidney Transplantation | 2 | 2020 | 570 | 0.120 |
Why?
|
| Psychotic Disorders | 1 | 2017 | 150 | 0.120 |
Why?
|
| Neuroimaging | 3 | 2022 | 376 | 0.110 |
Why?
|
| Neurons | 2 | 2015 | 1998 | 0.110 |
Why?
|
| Cell Death | 1 | 2015 | 241 | 0.110 |
Why?
|
| Oxygen Consumption | 1 | 2015 | 305 | 0.110 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2014 | 61 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 1 | 2015 | 396 | 0.110 |
Why?
|
| Dopamine | 1 | 2015 | 253 | 0.110 |
Why?
|
| Double-Blind Method | 1 | 2018 | 1658 | 0.110 |
Why?
|
| Glycolysis | 1 | 2014 | 166 | 0.100 |
Why?
|
| Logistic Models | 3 | 2024 | 1839 | 0.090 |
Why?
|
| Cell Line, Tumor | 2 | 2017 | 3678 | 0.090 |
Why?
|
| Cerebral Cortex | 1 | 2014 | 480 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 4752 | 0.080 |
Why?
|
| Humans | 12 | 2025 | 131934 | 0.070 |
Why?
|
| Gestational Age | 2 | 2024 | 1224 | 0.070 |
Why?
|
| Adult | 5 | 2024 | 31538 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 1131 | 0.070 |
Why?
|
| Prognosis | 1 | 2018 | 5007 | 0.070 |
Why?
|
| Time Factors | 1 | 2018 | 6440 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2015 | 3860 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 2438 | 0.060 |
Why?
|
| Male | 5 | 2025 | 64877 | 0.060 |
Why?
|
| Aged | 3 | 2025 | 21390 | 0.060 |
Why?
|
| Middle Aged | 3 | 2025 | 28947 | 0.060 |
Why?
|
| Term Birth | 1 | 2024 | 34 | 0.050 |
Why?
|
| Parity | 1 | 2024 | 84 | 0.050 |
Why?
|
| Mice | 3 | 2017 | 18461 | 0.050 |
Why?
|
| Young Adult | 3 | 2024 | 9952 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2025 | 308 | 0.050 |
Why?
|
| Amniotic Fluid | 1 | 2024 | 154 | 0.050 |
Why?
|
| Female | 5 | 2024 | 70592 | 0.050 |
Why?
|
| ROC Curve | 1 | 2024 | 600 | 0.050 |
Why?
|
| Anesthesia, Epidural | 1 | 2022 | 18 | 0.050 |
Why?
|
| Animals | 4 | 2017 | 34785 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2025 | 3830 | 0.050 |
Why?
|
| Chronopharmacokinetics | 1 | 2020 | 1 | 0.040 |
Why?
|
| Biological Availability | 1 | 2020 | 142 | 0.040 |
Why?
|
| Pregnancy | 2 | 2024 | 7543 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2020 | 152 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2020 | 328 | 0.040 |
Why?
|
| Emotions | 1 | 2022 | 367 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2022 | 6569 | 0.040 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2017 | 7 | 0.030 |
Why?
|
| Language Disorders | 1 | 2017 | 26 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2017 | 44 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2017 | 236 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2017 | 311 | 0.030 |
Why?
|
| Executive Function | 1 | 2017 | 126 | 0.030 |
Why?
|
| Ubiquitin | 1 | 2017 | 140 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2022 | 2312 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2017 | 172 | 0.030 |
Why?
|
| Proteolysis | 1 | 2017 | 195 | 0.030 |
Why?
|
| Biomarkers | 1 | 2025 | 3405 | 0.030 |
Why?
|
| RNA Interference | 1 | 2017 | 514 | 0.030 |
Why?
|
| Anxiety | 1 | 2021 | 991 | 0.030 |
Why?
|
| Methylnitronitrosoguanidine | 1 | 2014 | 2 | 0.030 |
Why?
|
| Glucose-6-Phosphate | 1 | 2014 | 5 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 687 | 0.030 |
Why?
|
| Hexokinase | 1 | 2014 | 26 | 0.030 |
Why?
|
| Acrylamides | 1 | 2014 | 24 | 0.030 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2014 | 26 | 0.030 |
Why?
|
| NAD | 1 | 2014 | 52 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2017 | 989 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2017 | 1608 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2014 | 615 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 1280 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1499 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2017 | 568 | 0.020 |
Why?
|
| Piperidines | 1 | 2014 | 235 | 0.020 |
Why?
|
| Mitochondrial Diseases | 1 | 2014 | 147 | 0.020 |
Why?
|
| Dementia | 1 | 2017 | 458 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2024 | 8542 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 2444 | 0.020 |
Why?
|
| Glucose | 1 | 2014 | 870 | 0.020 |
Why?
|
| United States | 1 | 2024 | 11650 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 3037 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 7097 | 0.010 |
Why?
|